MOMENTUM: Momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic

Srdan Verstovsek, Chih Cheng Chen, Miklós Egyed, Martin Ellis, Laura Fox, Yeow T. Goh, Vikas Gupta, Claire Harrison, Jean Jacques Kiladjian, Mihaela C. Lazaroiu, Adam Mead, Donal McLornan, Mary F. McMullin, Stephen T. Oh, Andrew Perkins, Uwe Platzbecker, Christof Scheid, Alessandro Vannucchi, Sung Soo Yoon, Mark M. Kowalski*Ruben A. Mesa

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'MOMENTUM: Momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic'. Together they form a unique fingerprint.

Medicine and Dentistry